Transplantation of embryonic dopamine neurons for severe Parkinson's disease

New England Journal of Medicine

Volumn 344, Issue 10, 2001, Pages 710-719

  Freed, Curt R ^a   Greene, Paul E ^b   Breeze, Robert E ^a   Tsai, Wei Yann ^b   DuMouchel, William ^c   Kao, Richard ^b   Dillon, Sandra ^b   Winfield, Howard ^b   Culver, Sharon ^a   Trojanowski, John Q ^d   Eidelberg, David ^e   Fahn, Stanley ^b  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b New York Presbyterian Columbia University Medical Center   (United States)

^c AT AND T LABS RESEARCH   (United States)

^d HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^e NORTH SHORE UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORINE 18; LEVODOPA;

ADULT; AGE; AGED; ARTICLE; CELL TRANSPLANTATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; DOUBLE BLIND PROCEDURE; DYSKINESIA; DYSTONIA; EMBRYO; FEMALE; HUMAN; HUMAN TISSUE; IMAGING; MAJOR CLINICAL STUDY; MALE; MESENCEPHALON; NERVE FIBER GROWTH; PARKINSON DISEASE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SURVIVAL;

BIOMEDICAL AND BEHAVIORAL RESEARCH; CLINICAL APPROACH/SOURCE; CONTROL GROUPS; EMPIRICAL APPROACH; PROFESSIONAL PATIENT RELATIONSHIP;

ADULT; AGE FACTORS; AGED; BRAIN; BRAIN TISSUE TRANSPLANTATION; CONTROL GROUPS; CULTURE TECHNIQUES; DIHYDROXYPHENYLALANINE; DOPAMINE; DOUBLE-BLIND METHOD; FEMALE; FETAL TISSUE TRANSPLANTATION; FLUORINE RADIOISOTOPES; HUMANS; MALE; MESENCEPHALON; MIDDLE AGED; NEURONS; PARKINSON DISEASE; SEVERITY OF ILLNESS INDEX; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0035826089     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM200103083441002     Document Type: Article

References (38)

1. Aromatic amino acids and modification of parkinsonism
2. Transplantation of human fetal dopamine cells for Parkinson's disease: Results at 1 year
3. Grafts of fetal dopamine neurons survive and improve motor function in Parkinson's disease
4. Fetal neural implants for Parkinson's disease: Results at 15 months
5. Survival of implanted fetal dopamine cells and neurologic improvement 12 to 46 months after transplantation for Parkinson's disease
6. Implantation of fetal tissue for the management of Parkinson's disease: A technical note
7. Embryonic dopamine cell implants as a treatment for the second phase of Parkinson's disease: Replacing failed nerve terminals
8. Unilateral transplantation of human fetal mesencephalic tissue into the caudate nucleus of patients with Parkinson's disease
9. Bilateral fetal mesencephalic grafting in two patients with parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)
10. Evidence for long-term survival and function of dopaminergic grafts in progressive Parkinson's disease
11. Fetal neural transplantation for Parkinson's disease
12. Lack of detectable systemic humoral/cellular allogeneic response in human and nonhuman primate recipients of embryonic mesencephalic allografts for the therapy of Parkinson's disease
13. Bilateral fetal nigral transplantation into the postcommissural putamen in Parkinson's disease
14. Neuropathological evidence of graft survival and striatal reinnervation after the transplantation of fetal mesencephalic tissue in a patient with Parkinson's disease
15. Bilateral motor improvement and alteration of L-dopa effect in two patients with Parkinson's disease following intrastriatal transplantation of foetal ventral mesencephalon
16. Long-term outcome of unilaterally transplanted parkinsonian patients. I. Clinical approach
17. Clinical study of fetal mesencephalic intracerebral transplants for the treatment of Parkinson's disease
18. Ten years' experience with fetal neurotransplantation in patients with advanced Parkinson's disease
19. Short- and long-term survival and function of unilateral intrastriatal dopaminergic grafts in Parkinson's disease
20. Long-term evaluation of bilateral fetal nigral transplantation in Parkinson disease
21. Dopamine release from nigral transplants visualized in vivo in a Parkinson's patient
22. Unified Parkinson's disease rating scale
23. Projection technique for evaluating surgery in Parkinson's disease
24. Core Assessment Program for Intracerebral Transplantations (CAPIT)
25. New fight over fetal tissue grafts
26. Double-blind controlled trial of human embryonic dopaminergic tissue transplants in advanced Parkinson's disease: Clinical outcomes
27. Double-blind controlled trial of human embryonic dopamine cell transplants in advanced Parkinson's disease: Study design, surgical strategy, patient demographics and pathological outcome
28. Double-blind placebo-controlled human fetal dopamine cell transplants in advanced Parkinson's disease
29. 18F-dopa uptake in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy
30. Input functions for 6-[fluorine-18]fluorodopa quantitation in parkinsonism: Comparative studies and clinical correlations
31. Comparative nigrostriatal dopaminergic imaging with iodine-123-beta CIT-FP/SPECT and fluorine-18-FDOPA/PET
32. Longitudinal data analysis using generalized linear models
33. Strands of embryonic mesencephalic tissue show greater dopamine neuron survival and better behavioral improvement than cell suspensions after transplantation in parkinsonian rats
34. Severe spontaneous dyskinesias: A disabling complication of embryonic dopaminergic tissue implants in a subset of transplanted patients with advanced Parkinson's disease
35. Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease: Pathophysiologic and clinical implications
36. Microstimulation of the primate neostriatum. II. Somatotopic organization of striatal microexcitable zones and their relation to neuronal response properties